Long-term Safety and Efficacy of Voclosporin in Black Patients with Lupus Nephritis: Results from the AURORA 1 and AURORA 2 Studies (ACR Convergence 2023) - Sep 24, 2023 - Abstract #1505; Pres time: Nov 13, 2023; 09:00 AM - 11:00 AM; Location: Poster Hall; in person; "Voclosporin in conjunction with low-dose glucocorticoids and mycophenolate mofetil (MMF) has shown significant benefit across ancestries and classes of LN. Black patients treated with a voclosporin-based regimen achieved higher rates of renal response than patients treated with MMF and glucocorticoids alone. For patients entering the continuation study, the response was largely durable for up to 3 years."
Clinical • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|
|
Gabriel Contreras1; Matt Baker2; Lucy Hodge2; Ernie Yap2
|